CN Patent
CN105732638B — 一种具有螺环或桥环结构的布鲁顿酪氨酸激酶抑制剂及其制备方法
Assigned to Chengdu Beite Pharmaceutical Co Ltd · Expires 2018-01-30 · 8y expired
What this patent protects
本发明公开了一种具有螺环或桥环结构的布鲁顿酪氨酸激酶抑制剂及其制备方法,该抑制剂包括式(Ⅰ),该抑制剂对BTK活性具有明显的抑制作用,在细胞水平上,对DOHH2细胞的抑制活性提高了近8倍,本发明提供的螺环或桥环化合物可用作BTK抑制剂,具有广阔的抗恶性肿瘤的应用前景。
USPTO Abstract
本发明公开了一种具有螺环或桥环结构的布鲁顿酪氨酸激酶抑制剂及其制备方法,该抑制剂包括式(Ⅰ),该抑制剂对BTK活性具有明显的抑制作用,在细胞水平上,对DOHH2细胞的抑制活性提高了近8倍,本发明提供的螺环或桥环化合物可用作BTK抑制剂,具有广阔的抗恶性肿瘤的应用前景。
Drugs covered by this patent
- Brukinsa (ZANUBRUTINIB) · BeiGene
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.